Skip to main content
Log in

Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba

  • New Anti-inflammatory Agents
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Paf-acether appears to be a potent mediator released in response to allergen exposure in sensitized animals and it could contribute to clinical manifestations of allergic asthma. In order to ascertain this assumption the inhibition of antigen-induced lung anaphylaxis in guinea-pig by BN 52021, a new highly specific paf-acether antagonist, was studied. Ovalbumin injected into passively sensitized guinea-pig induced a large bronchoconstriction which was accompanied by thrombocytopenia and leukopenia. Treatment of animals with BN 52021 i.v., five minutes before challenge, strongly (at the doses of 1 and 2 mg/kg) or totally (at 0.1 mg/kg) inhibited the bronchoconstriction and partially reduced the thrombocytopenia and leukopenia the thrombocytopenia occurring after challenge. These results confirm that paf-acether and platelets might play a key role in asthma. BN 52021 and other paf-acether antagonist could provide a new group of potent prophylactic anti-asthma drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. B.B. Vargaftig, M. Chignard, J. Benveniste, J. Lefort andF. Wal,Background and present status of research on platelet activating factor (paf-acether), Ann. N.Y. Acad. Sci.370, 119–137 (1981).

    PubMed  Google Scholar 

  2. J. Benveniste, P.M. Henson andC.G. Cochrane,Leukocyte-dependent histamine release from rabbit platelet. The role of IgE, basophils and platelet activating factor, J. Exp. Med.136, 1356–1377 (1972).

    Google Scholar 

  3. B.B. Vargaftig, J. Lefort, M. Chignard andJ. Benveniste,Platelet activating factor induced platelet dependent-bronchoconstriction unrelated to the formation of prostaglandin derivates, Eur. J. Pharmacol.65, 185–192 (1980).

    Article  PubMed  Google Scholar 

  4. G.S. Basran, C.P. Page, W. Paul andJ. Morley,Platelet activating factor possible mediator of the dual response to allergen? Clin. Allergy.14, 75–79 (1984).

    PubMed  Google Scholar 

  5. P.G. Braquet,Treatment and prevention of paf-acether-induced sickness by a new series of highly specific inhibitors, G.B. Patent 8, 418–424 (1984).

    Google Scholar 

  6. C. Touvay, B. Vilain, J.E. Taylor, A. Etienne, P.E. Chabrier andP. Braquet,Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist, BN 52021, Prog. Lipid Res., (in press).

  7. J. Morley, S. Sanjar andC.P. Page,The platelet in asthma, Lancet, 1142–1144 (1984).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Touvay, C., Etienne, A. & Braquet, P. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. Agents and Actions 17, 371–372 (1986). https://doi.org/10.1007/BF01982650

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01982650

Keywords

Navigation